m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00708)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
NLRP1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | HUVEC cell line | Homo sapiens |
Treatment: shMETTL3 HUVEC cells
Control: shScramble HUVEC cells
|
GSE157544 | |
Regulation |
|
logFC: -7.83E-01 p-value: 2.96E-03 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | In the in vivo atherosclerosis model,partial ligation of the carotid artery led to plaque formation and up-regulation of METTL3 and NACHT/LRR/PYD domains-containing protein 1 (NLRP1), with down-regulation of KLF4; knockdown of METTL3 via repetitive shRNA administration prevented the atherogenic process, NLRP3 up-regulation, and KLF4 down-regulation. Collectively, it has demonstrated that METTL3 serves a central role in the atherogenesis induced by oscillatory stress and disturbed blood flow. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Atherosclerosis | ICD-11: BD40.Z | ||
In-vitro Model | MAEC | Normal | Mus musculus | CVCL_U411 |
HUVEC-C | Normal | Homo sapiens | CVCL_2959 | |
Atherosclerosis [ICD-11: BD40]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | In the in vivo atherosclerosis model,partial ligation of the carotid artery led to plaque formation and up-regulation of METTL3 and NACHT/LRR/PYD domains-containing protein 1 (NLRP1), with down-regulation of KLF4; knockdown of METTL3 via repetitive shRNA administration prevented the atherogenic process, NLRP3 up-regulation, and KLF4 down-regulation. Collectively, it has demonstrated that METTL3 serves a central role in the atherogenesis induced by oscillatory stress and disturbed blood flow. | |||
Responsed Disease | Atherosclerosis [ICD-11: BD40.Z] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Up regulation | |||
In-vitro Model | MAEC | Normal | Mus musculus | CVCL_U411 |
HUVEC-C | Normal | Homo sapiens | CVCL_2959 | |